Targeting NEDD8 in pediatric acute myeloid leukemia: an integrated bioinformatics and experimental approach
Authors:
Open Access
- 18 March 2025
- journal article
- Published by Taylor & Francis in Hematology
- Vol. 30 (1) , 2478650
Abstract
SUMMARYThis study systematically explored the role of NEDD8 in pediatric acute myeloid leukemia (AML) through patient sample analysis, database mining, and in vitro experiments. Our results demonstrated that NEDD8 was significantly overexpressed in newly diagnosed pediatric AML patients and was associated with poor survival outcomes. Functional enrichment analysis of the TARGET database further revealed a strong correlation between NEDD8 and cancer-related pathways. In vitro experiments showed that NEDD8 knockdown significantly inhibited the proliferation of AML cells (THP-1 and MV4-11) and induced cell cycle arrest. Collectively, these findings highlight the critical role of NEDD8 in pediatric AML pathogenesis and suggest its potential as both a prognostic biomarker and a therapeutic target.Keywords
Funding Information
- National Natural Science Foundation of China (82060675, 82260036)
- Guizhou Provincial Science and Technology Projects (QKHCG-2024-ZD012, QKHJCZK-2024-YB306)
- Guizhou Provincial High- Level (‘Thousand’ Level) Innovative Talents Projects (GZWJRS-2023-034, GZWJRS-2023-041)
- Zunyi Science and Technology Plan Project (ZSKRPT-2023-6, ZSKHZ-2023-219)
This publication has 29 references indexed in Scilit:
- Inhibiting neddylation: A new strategy for tumor therapyJournal of Pharmaceutical Analysis, 2024
- Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell CarcinomaMolecular Therapy Nucleic Acids, 2020
- Effective targeting of the ubiquitin-like modifier NEDD8 for lung adenocarcinoma treatmentCell Biology and Toxicology, 2020
- Targeting SCF E3 Ligases for Cancer Therapies2020
- Protein neddylation and its alterations in human cancers for targeted therapyCellular Signalling, 2018
- Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic targetCell Death & Disease, 2017
- The covalent modifier Nedd8 is critical for the activation of Smurf1 ubiquitin ligase in tumorigenesisNature Communications, 2014
- NEDD8 Pathways in Cancer, Sine Quibus NonCancer Cell, 2011
- An inhibitor of NEDD8-activating enzyme as a new approach to treat cancerNature, 2009
- Regulation of G1 cyclin-dependent kinases in the mammalian cell cycleCurrent Opinion in Cell Biology, 2000